Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (161-170 of 350) with videos related to

Pageof 35
Sort By:
Experimental Hematology|June 1, 1991
Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-betaM Wetzler, M Talpaz, D G Lowe, et al.
Leukemia|July 1, 1997
A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.
Leukemia|June 1, 1997
Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabineJ Cortes, H Kantarjian, M Talpaz, et al.
Leukemia|May 1, 1997
Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three casesL Fayad, H Kantarjian, S O'Brien, et al.
Leukemia|February 29, 2008
Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1(T315I) and other mutants compared to direct sequencing of the ABL1 kinase domainA Quintás-Cardama, D L Gibbons, H Kantarjian, et al.
British Journal of Haematology|August 1, 1985
Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferonM Talpaz, J M Trujillo, W N Hittelman, et al.
Journal of Immunological Methods|July 15, 1983
Objective evaluation of local xenogeneic graft-versus-host reaction by computerized radioisotope imaging (CRI)M Talpaz, E Kim, M Guardini, et al.
Cancer|December 18, 2001
Homoharringtonine: history, current research, and future directionH M Kantarjian, M Talpaz, V Santini, et al.
Annals of Internal Medicine|February 15, 1995
Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia ServiceH M Kantarjian, T L Smith, S O'Brien, et al.
Leukemia|February 1, 1991
Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemiaZ Estrov, M Talpaz, T C Chou, et al.
Pageof 35

Showing results (161-170 of 350) with videos related to

Sort By:
Pageof 35
Experimental Hematology|June 1, 1991
Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-betaM Wetzler, M Talpaz, D G Lowe, et al.
Leukemia|July 1, 1997
A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.
Leukemia|June 1, 1997
Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabineJ Cortes, H Kantarjian, M Talpaz, et al.
Leukemia|May 1, 1997
Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three casesL Fayad, H Kantarjian, S O'Brien, et al.
Leukemia|February 29, 2008
Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1(T315I) and other mutants compared to direct sequencing of the ABL1 kinase domainA Quintás-Cardama, D L Gibbons, H Kantarjian, et al.
British Journal of Haematology|August 1, 1985
Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferonM Talpaz, J M Trujillo, W N Hittelman, et al.
Journal of Immunological Methods|July 15, 1983
Objective evaluation of local xenogeneic graft-versus-host reaction by computerized radioisotope imaging (CRI)M Talpaz, E Kim, M Guardini, et al.
Cancer|December 18, 2001
Homoharringtonine: history, current research, and future directionH M Kantarjian, M Talpaz, V Santini, et al.
Annals of Internal Medicine|February 15, 1995
Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia ServiceH M Kantarjian, T L Smith, S O'Brien, et al.
Leukemia|February 1, 1991
Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemiaZ Estrov, M Talpaz, T C Chou, et al.
Pageof 35